Goto Satoshi
Department of Clinical Neuroscience, Institute of Health Bioscience, Graduate School of Medical Science, University of Tokushima.
Rinsho Shinkeigaku. 2007 Nov;47(11):948-50.
The introduction of deep brain stimulation (DBS) was a historical step forward for the treatment of advanced and medically intractable movement disorders that include Parkinson's disease, dystonias, essential tremor, and Holmes' tremor. DBS is able to modulate the target region electrically in a reversible and adjustable fashion in contrast to an irreversible and destructive lesioning procedure. In the treatment of movement disorders, the potential targets are the thalamic ventral intermediate nucleus (Vim), globus pallidus internus (GPi), subthalamic nucleus (STN), pedunculopontine nucleus (PPN), and thalamic Vo-complex nucleus. With the development of DBS technology and stereotactic neurosurgical techniques, its therapeutic efficacy has been increased while reducing surgical complications. DBS has become an established therapy for disabling movement disorders and is currently being used to treat neuropsychiatric disorders.
深部脑刺激(DBS)的引入是治疗包括帕金森病、肌张力障碍、特发性震颤和霍尔姆斯震颤在内的晚期及药物难治性运动障碍的一个历史性进步。与不可逆且具有破坏性的毁损手术不同,DBS能够以可逆且可调节的方式对目标区域进行电调节。在运动障碍的治疗中,潜在靶点包括丘脑腹中间核(Vim)、苍白球内侧部(GPi)、丘脑底核(STN)、脚桥核(PPN)以及丘脑Vo复合核。随着DBS技术和立体定向神经外科技术的发展,其治疗效果得到提高,同时手术并发症减少。DBS已成为治疗致残性运动障碍的既定疗法,目前正用于治疗神经精神疾病。